Financial Summary for the May 2026 Period [Japan GAAP] (Consolidated)

Overview of Results

Aoki Pharmacy Holdings posted consolidated results for the May 2026 period with net sales of 566,865 million yen, up 13.0% year on year, operating income of 27,096 million yen, up 1.9%, and ordinary income of 27,722 million yen, up 0.8%. Net income attributable to owners of the parent was 17,133 million yen, down 3.7%. The earnings release notes growth strategy driven by store expansion and the expansion of in-store dispensing, as well as external pressures such as high raw material and personnel costs, and outlines the investment policy for future expansion. For the next period, expected net sales of 6,400 billion yen, operating income of 320 billion yen, ordinary income of 308 billion yen, and net income of 190 billion yen are forecast.

Capital Policy & Dividend Trends

Year-end dividend of 48 yen (8 yen year-end dividend and 40 yen commemorative dividend) is recorded. There are notes on treasury stock acquisition/retirement, and shareholder capital changes are concentrated in certain years. In this earnings release, payout ratio and treasury stock movements are important points from the perspective of capital allocation.